EUVIMEDObjevte EUVIMED
Crossref

Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors

Seyit Ali Güngör

Chemical Biology & Drug Design · 2023-10 · 102 (4) · 676-691

DOI: 10.1111/cbdd.14274 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2023-05-31. Written by Seyit Ali Güngör. Institution: Department of Chemistry, Faculty of Science, Kahramanmaras Sütcü Imam University, Kahramanmaras, Turkey. Major MEDLINE topics: Cholinesterase Inhibitors, Butyrylcholinesterase. Cited 22 times so far (Crossref); 56 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

A series of hydrazide‐hydrazone imine derivative compounds (3a–k) were synthesized and their structures characterized using FTIR, 1 H, and 13 C (NMR) spectroscopic methods. In addition, molecular structures of compounds 3a, 3d, and 3g were elucidated by X‐ray diffraction technique. In vitro inhibition activities of hydrazide‐hydrazone imine derivatives against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) were investigated. Compound 3i (IC 50 = 2.01 μM) exhibited the best inhibitory activity against AChE, comparable to the control Galantamine (IC 50 = 2.60 μM). Against BChE, compound 3h (IC 50 = 2.83 μM) showed the best inhibitory property which is higher control Galantamine (IC 50 = 3.70 μM). The Ki values of compound 3i (Ki = 0.63 μM) and compound 3h (Ki = 0.94 μM) that have the strongest inhibitory potential were determined against AChE and BChE, respectively. According to the docking result, the most stable conformation of AChE and compound 3i showed that it has a binding affinity of −10.82 kcal/moL. The binding affinity of the most stable conformation formed by BChE and compound 3h is −8.60 kcal/moL. Finally, in silico results and pharmacokinetic parameters of ADME showed that these compounds have good oral bioavailability properties.

Subjects

MeSH terms (MEDLINE)

Cholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesteraseHydrazonesHydrazinesGalantamineStructure-Activity RelationshipMolecular Docking SimulationMolecular Structure

Author keywords

ADMEcholinesterasehydrazide-hydrazoneinhibitorsmolecular docking

Substances

Cholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesteraseHydrazonesHydrazinesGalantamine

Authors and institutions

  • Department of Chemistry, Faculty of Science, Kahramanmaras Sütcü Imam University, Kahramanmaras, Turkey.

Cite

APA

Güngör, S. A. (2023). Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors. Chemical Biology & Drug Design, 102(4), 676-691. https://doi.org/10.1111/cbdd.14274

Vancouver

Güngör SA. Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors. Chemical Biology & Drug Design. 2023;102(4):676-691. doi:10.1111/cbdd.14274

BibTeX
@article{Gngr2023,
  author = {Güngör, Seyit Ali},
  title = {Synthesis, in silico and in vitro studies of hydrazide‐hydrazone imine derivatives as potential cholinesterase inhibitors},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {4},
  pages = {676--691},
  doi = {10.1111/cbdd.14274}
}
Start for free →